News & Updates

Monthly subcutaneous injections of the anti–CGRP-receptor monoclonal antibody erenumab appear to be beneficial in the management of flushing and chronic redness among individuals with rosacea, according to a study.

Administering once-weekly pulsed dye laser (PDL) treatments to infants with port-wine birthmark in the first few months of life appears safe and leads to significant improvements in the involved skin areas, as shown in a small retrospective study.

Tirbanibulin 1% ointment proves safe and effective in patients with multiple actinic keratoses (AKs) treated in real-world settings, as shown in a study.

A novel infant microbiome formula (SIM03) containing unique Bifidobacterium bifidum and Bifidobacterium breve strains improves eczema severity and quality of life (QoL) in preschool children, shows a study by the Chinese University of Hong Kong (CUHK).

Adding desloratadine to an isotretinoin regimen appears to reduce pruritus in acne, leading to a higher patient satisfaction, as shown in a study.

Treatment with upadacitinib, an oral selective Janus kinase inhibitor, led to greater proportions of days spent with improved nighttime itch and sleep disturbance experienced by patients with moderate-to-severe atopic dermatitis (AD), according to an integrated analysis of the phase III Measure Up 1 and 2 studies presented at AAD 2024.